Published in Bioconjug Chem on February 04, 1997
3'-minor groove binder-DNA probes increase sequence specificity at PCR extension temperatures. Nucleic Acids Res (2000) 5.24
Oligonucleotides with conjugated dihydropyrroloindole tripeptides: base composition and backbone effects on hybridization. Nucleic Acids Res (1997) 1.32
3'-minor groove binder-DNA probes increase sequence specificity at PCR extension temperatures. Nucleic Acids Res (2000) 5.24
Efficient priming of PCR with short oligonucleotides conjugated to a minor groove binder. Nucleic Acids Res (1997) 2.29
Facile preparation of nuclease resistant 3' modified oligodeoxynucleotides. Nucleic Acids Res (1993) 1.51
Oligodeoxyribonucleotides with conjugated dihydropyrroloindole oligopeptides: preparation and hybridization properties. Bioconjug Chem (1995) 1.45
Oligonucleotides containing 2-aminoadenine and 2-thiothymine act as selectively binding complementary agents. Biochemistry (1996) 1.42
Sequence-specific arrest of primer extension on single-stranded DNA by an oligonucleotide-minor groove binder conjugate. Proc Natl Acad Sci U S A (1996) 1.35
Oligonucleotides with conjugated dihydropyrroloindole tripeptides: base composition and backbone effects on hybridization. Nucleic Acids Res (1997) 1.32
Analogs of cyclic AMP and cyclic GMP: general methods of synthesis and the relationship of structure to enzymic activity. Life Sci (1974) 1.27
Induction of hepatic tyrosine aminotransferase in vivo by derivatives of cyclic adenosine 3':5'-monophosphate. J Biol Chem (1975) 1.16
Electromechanical Fredericks effects in nematic gels. Phys Rev E Stat Phys Plasmas Fluids Relat Interdiscip Topics (1999) 1.16
2' Derivatives of guanosine and inosine cyclic 3',5'-phosphates. Synthesis, enzymic activity, and the effect of 8-substituents. Biochemistry (1976) 1.13
G/C-modified oligodeoxynucleotides with selective complementarity: synthesis and hybridization properties. Nucleic Acids Res (1996) 1.11
Triplex targeting of a native gene in permeabilized intact cells: covalent modification of the gene for the chemokine receptor CCR5. Nucleic Acids Res (1998) 1.03
Solution structure of a highly stable DNA duplex conjugated to a minor groove binder. Nucleic Acids Res (1998) 1.03
Acridine- and cholesterol-derivatized solid supports for improved synthesis of 3'-modified oligonucleotides. Bioconjug Chem (1992) 1.00
Antiviral activity of 3-deazaguanine, 3-deazaguanosine, and 3-deazaguanylic acid. Antimicrob Agents Chemother (1977) 1.00
Oligonucleotides complementary to a promoter over the region -8...+2 as transcription primers for E. coli RNA polymerase. Nucleic Acids Res (1984) 0.97
Synthesis and high stability of complementary complexes of N-(2-hydroxyethyl)phenazinium derivatives of oligonucleotides. Bioconjug Chem (1992) 0.95
Synthesis of 3-deazaguanine, 3-deazaguanosine, and 3-deazaguanylic acid by a novel ring closure of imidazole precursors. J Am Chem Soc (1976) 0.94
Sequence-specific covalent modification of DNA by cross-linking oligonucleotides. Catalysis by RecA and implication for the mechanism of synaptic joint formation. Biochemistry (1995) 0.94
Factors influencing the extent and regiospecificity of cross-link formation between single-stranded DNA and reactive complementary oligodeoxynucleotides. Biochemistry (1994) 0.87
Synthesis and reactivity of aryl nitrogen mustard-oligodeoxyribonucleotide conjugates. Bioconjug Chem (1998) 0.87
2,5-Anhydro-1-deoxy-1-phosphono-D-altritol, an isosteric analogue of alpha-D-ribofuranose 1-phosphate. J Med Chem (1984) 0.87
Synthesis and antiviral acticity of some phosphates of the broad-spectrum antiviral nucleoside, 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (ribavirin). J Med Chem (1978) 0.87
An improved CPG support for the synthesis of 3'-amine-tailed oligonucleotides. Bioconjug Chem (1992) 0.86
Factors influencing the extent and selectivity of alkylation within triplexes by reactive G/A motif oligonucleotides. Nucleic Acids Res (1997) 0.86
Studies of the functional topography of Escherichia coli RNA polymerase. Affinity labelling of RNA polymerase in a promoter complex by phosphorylating derivatives of primer oligonucleotides. Eur J Biochem (1987) 0.85
Synthesis and biological activity of several 6-substituted 9- -D-ribofuranosylpurine 3',5',-cyclic phosphates. Biochemistry (1972) 0.85
Synthesis, intramolecular hydrogen bonding, and biochemical studies of clitocine, a naturally occurring exocyclic amino nucleoside. J Med Chem (1988) 0.85
RecA-catalyzed, sequence-specific alkylation of DNA by cross-linking oligonucleotides. Effects of length and nonhomologous base substitutions. Biochemistry (1996) 0.84
Preparation and hybridization properties of oligonucleotides containing 1-alpha-D-arabinofuranosylthymine. Nucleic Acids Res (1991) 0.83
Thymidine phosphorylase. Substrate specificity for 5-substituted 2'-deoxyuridines. J Med Chem (1980) 0.82
Rapid and efficient hybridization-triggered crosslinking within a DNA duplex by an oligodeoxyribonucleotide bearing a conjugated cyclopropapyrroloindole. Nucleic Acids Res (1996) 0.82
Nucleosides of 1,4-thiazin-3-one and derivatives as tetrahedral intermediate analogues of enzymes in pyrimidine nucleoside metabolism. J Med Chem (1988) 0.81
Antisense oligonucleotides containing modified bases inhibit in vitro translation of Leishmania amazonensis mRNAs by invading the mini-exon hairpin. J Biol Chem (1999) 0.81
Design and synthesis of tetrahedral intermediate analogues as potential dihydroorotase inhibitors. J Med Chem (1984) 0.81
In vitro antiviral activity of 6-substituted 9-beta-D-ribofuranosylpurine 3', 5'-cyclic phosphates. Antimicrob Agents Chemother (1974) 0.81
Minor groove DNA alkylation directed by major groove triplex forming oligodeoxyribonucleotides. Nucleic Acids Res (1997) 0.80
Sequence-specific targeting and covalent modification of human genomic DNA. Nucleic Acids Res (1997) 0.80
Synthesis and enzymatic and inotropic activity of some new 8-substituted and 6,8-disubstituted derivatives of adenosine cyclic 3',5'-monophosphate. J Med Chem (1980) 0.80
Linkers designed to intercalate the double helix greatly facilitate DNA alkylation by triplex-forming oligonucleotides carrying a cyclopropapyrroloindole reactive moiety. Nucleic Acids Res (1999) 0.80
Synthesis of fused [1,2,6]thiadiazine 1,1-dioxides as potential transition-state analogue inhibitors of xanthine oxidase and guanase. J Med Chem (1979) 0.80
Letter: A new class of potent guanine antimetabolites. Synthesis of 3-deazaguanine, 3-deazaguanosine, and 3-deazaguanylic acid by a novel ring closure of imidazole precursors. J Am Chem Soc (1975) 0.80
Inhibitors of inosinic acid dehydrogenase. 2-Substituted inosinic acids. J Med Chem (1984) 0.79
Irreversible enzyme inhibitors. LXXXIV. Candidate active-site-directed irreversible inhibitors of dihydrofolic reductase. IX. Derivatives of 2,4-diaminopyrimidine. 3. J Pharm Sci (1967) 0.78
Inhibition of inosinic acid dehydrogenase by 8-substituted purine nucleotides. J Med Chem (1981) 0.78
Enhancement of interferon antiviral action in L-cells by cyclic nucleotides. Proc Soc Exp Biol Med (1974) 0.78
Sequence-specific chemical modification of a hybrid bacteriophage M13 single-stranded DNA by alkylating oligonucleotide derivatives. FEBS Lett (1988) 0.78
Pyridine nucleosides related to 5-fluorouracil and thymine. J Med Chem (1973) 0.77
Effect of modification of the 1-, 2-, and 6-positions of 9-beta-D-ribofuranosylpurine cyclic 3',5'-phosphate on the cyclic nucleotide specificity of adenosine cyclic 3',5'-phosphate- and guanosine cyclic 3',5'-phosphate-dependent protein kinases. Biochem Pharmacol (1981) 0.77
Modulation of Cm/T, G/A, and G/T triplex stability by conjugate groups in the presence and absence of KCl. Biochemistry (1997) 0.77
Synthesis of some 1, 8- and 2, 8-disubstituted derivatives of adenosine cyclic 3', 5'-phosphate and their interaction with some enzymes of cAMP metabolism. J Med Chem (1976) 0.77
Synthesis and enzymic studies of 5-aminoimidazole and N-1-and N6-substituted adenine ribonucleoside cyclic 3',5'-phosphates prepared from adenosine cyclic 3',5'-phosphate. J Med Chem (1973) 0.76
Targeted mutagenesis of DNA with alkylating RecA assisted oligonucleotides. Nucleic Acids Res (1999) 0.75
Genetic testing legislation: a review of the past two years. J Insur Med (1998) 0.75
Adenosine cyclic 3',5',-monophosphate phosphodiesterasr inhibitors. 2.3-Substituted 5,7-dialkylpyrazolo [1,5-a]pyrimidines. J Med Chem (1975) 0.75
2'-O-Acyl-6-thioinosine cyclic 3',5'-phosphates as prodrugs of thioinosinic acid. J Med Chem (1979) 0.75
A novel biotinylated adenylate analogue derived from pyrazolo[3,4-d]pyrimidine for labeling DNA probes. Bioconjug Chem (1992) 0.75
[Diagnostic significance of so-called Veraguth's upper lid folds in depressions]. Schweiz Arch Neurol Neurochir Psychiatr (1970) 0.75
Structure-activity relationships of cytotoxic cholesterol-modified DNA duplexes. J Med Chem (1995) 0.75
A new purine ring closure and the synthesis of 2-substituted derivatives of adenosine cyclic 3',5'-phosphate. J Am Chem Soc (1974) 0.75
Structure of two hydroxylated metabolites of ftorafur. Biochem Pharmacol (1980) 0.75
Discovery of short, 3'-cholesterol-modified DNA duplexes with unique antitumor cell activity. Cancer Res (1994) 0.75
6-aminopyrazolo[4,3-c]pyridin-4(5H)-one, a novel analogue of guanine. J Med Chem (1977) 0.75
Transmission studies of Bovine anaplasmosis with the horseflies, Tabanus fuscicostatus and Tabanus nigrovittatus. Am J Vet Res (1966) 0.75
Irreversible enzyme inhibitors. LXXXII. Candidate active-site-directed irreversible inhibitors of dihydrofolic reductase. VII. Derivatives of 2,4-diaminopyrimidine. I. J Pharm Sci (1967) 0.75
Irrevesible enzyme inhibitors. CLI. Active-site-directed irreversible inhibitors of dihydrofolic reductase derived from 5-(p-aminophenylbutyl)-2,4-diaminopyrimidines with a terminal sulfonyl fluoride. J Med Chem (1969) 0.75
2-substituted derivatives of adenosine and inosine cyclic 3',5'-phosphate. Synthesis, enzymic activity, and analysis of the structural requirements of the binding locale of the 2-substituent on bovine brain protein kinase. Biochemistry (1975) 0.75
Synthesis and enzymic activity of 8-acyl and 8-alkyl derivatives of guanosine 3, 5-cyclic phosphate. Biochemistry (1975) 0.75
Irreversible enzyme inhibitors. CXVI. Active-site-directed irreversible inhibitors of dihydrofolic reductase derived from 6-substituted 2,4-diamino-5-phenylpyrimidines. 3. J Med Chem (1968) 0.75
Irreversible enzyme inhibitors. 133. Studies on differential irreversible inhibition of dihydrofolic reductase from three strains of L1210 leukemia, liver, spleen, and intestine of the mouse. J Med Chem (1969) 0.75
Irreversible enzyme inhibitors. CLIV. Some factors in cell wall transport of active-site-directed irreversible inhibitors of dihydrofolic reductase derived from 5-substituted 2,4-diaminopyrimidines. J Med Chem (1969) 0.75